1                        Exercising women with oligomenorrhea/amenorrhea (Oligo/Amen) were randomly ass

2 manent amenorrhea, temporary amenorrhea, and oligomenorrhea among different regimens; and (4) analyze

3      In affected sisters, only one-half have oligomenorrhea and hyperandrogenemia characteristic of P

4 l irregularities (approximately 23%) such as oligomenorrhea and menorrhagia.

5 perprolactinemia, two of whom presented with oligomenorrhea and one with infertility.

6 wth trajectory; pubertal delay; bradycardia; oligomenorrhea; and amenorrhea).

7                                     Although oligomenorrhea has been associated cross-sectionally wit

8 us, CRA (early and late), temporary CRA, and oligomenorrhea in the setting of adjuvant treatment.

9 gation of hyperandrogenemia (with or without oligomenorrhea) in PCOS kindreds.

10 glucose intolerance, it is not known whether oligomenorrhea is a marker for increased future risk of

11 ommon, and 492 women (pre-PCOS subgroup) had oligomenorrhea (n = 75), hyperandrogenism (n = 257), or

12 te (n = 8, hyperandrogenism), or low (n = 7, oligomenorrhea or amenorrhea) suspicion of PCOS.

13 irls with high (n = 40, hyperandrogenism and oligomenorrhea or amenorrhea), intermediate (n = 8, hype

14 cific symptomatology in these women, such as oligomenorrhea or hirsutism.

15 rs) girls with no clinical hyperandrogenism, oligomenorrhea, or amenorrhea.

16 n with partial phenotypes (hyperandrogenism, oligomenorrhea, or polycystic morphology labeled as pre-

17 history elements (eg, fever, hypertrichosis, oligomenorrhea) were important, they regularly failed to